Attracting EIC funding for Alzinova´s disease modifying therapeutic vaccine from Alzheimer’s disease
| Reference number | |
| Coordinator | Alzinova AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | October 2023 - January 2024 |
| Status | Completed |
| Venture | Preparation projects for international application within health |
| Call | Preparation project for international proposal in health and food 2023 |
Important results from the project
The purpose of the financial support was to help Alzinova with a successful EIC Accelerator application. Since the phase 1 proposal was accomplished with successful results, Alzinova will enter Phase 2 of the EIC proposal.
Expected long term effects
With financing from Vinnova, Alzinova was able to implement the first proposal in EICs Accelerator program. Among others, Alzinova was selected to proceed to Phase 2 and is now about to submit proposal for Phase 2 which will take place on March 13, 2024. With funding from Vinnova, Alzinova could focus on writing a well-founded proposal that focused on the core business and its possible impacts for future use.
Approach and implementation
With funding from Vinnova, Alzinova was able to bring in external experts and together with them implement a well-written proposal supported by facts and arguments relevant to the EIC. Together with the above consultants, Alzinova was able to create a proposal that managed to get approved through EIC phase 1 and which hopefully also proves to be good enough for an approved phase 2.